# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-14-000807
Filing Date
2014-02-12
Accepted
2014-02-12 16:22:10
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT TO REGISTRATION STATEMENT | fs12014a1_actinium.htm | S-1/A | 2910591
2 | OPINION OF HISCOCK & BARCLAY, LLP | fs12014a1ex5i_actinium.htm | EX-5.1 | 8365
3 | CONSENT OF GBH CPAS, PC | fs12014a1ex23i_actinium.htm | EX-23.1 | 2978
4 |  | logo.jpg | GRAPHIC | 7982
| Complete submission text file | 0001213900-14-000807.txt |  | 11666414

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 |  | fil-20130930.xml | EX-101.INS | 1657439
6 |  | fil-20130930.xsd | EX-101.SCH | 88179
7 |  | fil-20130930_cal.xml | EX-101.CAL | 46616
8 |  | fil-20130930_def.xml | EX-101.DEF | 303662
9 |  | fil-20130930_lab.xml | EX-101.LAB | 619077
10 |  | fil-20130930_pre.xml | EX-101.PRE | 437791

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-193714 | Film No.: 14600536
SIC: 6770 Blank Checks